|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,341.00 JPY | -1.61% |
|
-0.85% | +3.83% |
| 07-17 | Keros Initiates Dosing in Phase 3 Anemia Trial, Triggering $10 Million Milestone Payment From Takeda | MT |
| 07-14 | Sector Update: Health Care Stocks Decline Premarket Monday | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Other Pharmaceuticals | -1.61% | -0.85% | +3.83% | +1.31% | +16.98% | 46.18B |  | | |
Technical Rankings Surperformance
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition